NLRP3 and colitis: We found that oral administration of DSS in NLRP3−/− mice induced a less severe colitis than WT mice and produced lower levels of MPO and IL-1β in colonic tissues, which suggested the important role of NLRP3 inflammasome in DSS-induced colitis.